The focus of this seminar is on prescription smoking cessation pharmacotherapies, which include nicotine replacement therapy patches, varenicline and bupropion.
Dr Alys Havard presents data on the number of Australian women who use these...
New psychoactive substances (NPS) are spreading at an unprecedented rate and are becoming a serious health threat and a real problem in drug policy in Central Asian countries. Little is known about the negative impact of NPS on human health...
Togo's Ministry of Health, Public Hygiene and Universal Access to Care has set up a national psychoactive drug addiction programme (PNAPP) that will help improve access to care for people with substance use problems.
This program will work...
‘DANGEROUS DATA’ PART 7: CONTROLLED DRINKING VERSUS ABSTINENCE: WHO DECIDES?
The history of the controlled drinking controversy makes us face not just what decision is made about treatment goals, but who makes that decision; where the...
People with mental health issues are more likely to smoke compared to the general population. They are also more likely to experience severe withdrawals and are less responsive to treatment. Indeed, some people believe that quitting smoking...
Chile has one of the highest rates of alcohol use per capita in the Americas. Policy to reduce alcohol-related harm is often up against resistance from alcohol industry, policymakers and the public.
This review, published in the Journal of...
This paper reviews the international evidence on approaches to drug law reform, focussing on case studies from Australia, Canada, Denmark, Portugal and The Netherlands.
It seeks to support the ongoing development of innovative approaches...
CARE AND CONTROL: HOW FAR SHOULD COLLABORATION GO?
Key review argues that criminal justice and treatment conducted in a criminal justice context should see themselves as partners in a common effort, but one is geared to protecting society...
The ‘SSA Addictions Professorship’ scheme aims to support individuals who are already senior academics with established expertise and who wish to move to become part of UK academic growth in addictions research, but who would face potential...
